institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 12 days ago • loading... • Updated 12 days ago

Innovent Announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China Were Orally Presented at ADA 85th Scientific Sessions

Summary by PR Newswire

/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

11 Articles

11 Articles

All

Left

1

Center

5

Right

1

Gilbert Sun News

+9 Reposted by 9 other sources

Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented at ADA 85th Scientific Sessions

SAN FRANCISCO and SUZHOU, China, June 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major…

12 days ago

Read Full Article

Innovent announces the Phase 3 Clinical Study DREAMS-1 of Mazdutide in China were Orally Presented ...

SAN FRANCISCO and SUZHOU, China, June 24, 2025

12 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources11

Leaning Left1Leaning Right1Center5Last Updated11 days agoBias Distribution

71% Center

Bias Distribution

71% of the sources are Center

71% Center

Untracked bias

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

World News broke the news in United States 12 days ago on Tuesday, June 24, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics